NCT02567370View on ClinicalTrials.gov

Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581

PHASE1CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions

Schizophrenia or Schizoaffective Disorder

Interventions

DRUG

AMG 581

Active drug

DRUG

Placebo

Placebo

Trial Locations (1)

91206

Research Site, Glendale

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY